Compare Edelweiss Financial with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

EDELWEISS FINANCIAL vs INDOCO REMEDIES - Comparison Results

EDELWEISS FINANCIAL     Change

Edelweiss is among the larger institutional brokerage firms in India, with a strong domestic investment-banking business. It has a good market share in the institutional broking, and strong presence in derivatives. While its strengths remain in priva... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    EDELWEISS FINANCIAL INDOCO REMEDIES EDELWEISS FINANCIAL/
INDOCO REMEDIES
 
P/E (TTM) x 6.6 111.5 5.9% View Chart
P/BV x 0.9 1.9 48.1% View Chart
Dividend Yield % 1.8 0.7 244.0%  

Financials

 EDELWEISS FINANCIAL   INDOCO REMEDIES
EQUITY SHARE DATA
    EDELWEISS FINANCIAL
Mar-18
INDOCO REMEDIES
Mar-18
EDELWEISS FINANCIAL/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs309317 97.5%   
Low Rs157178 88.0%   
Sales per share (Unadj.) Rs93.7113.1 82.9%  
Earnings per share (Unadj.) Rs9.74.5 217.7%  
Cash flow per share (Unadj.) Rs10.911.8 92.6%  
Dividends per share (Unadj.) Rs1.351.00 135.0%  
Dividend yield (eoy) %0.60.4 143.5%  
Book value per share (Unadj.) Rs72.973.2 99.5%  
Shares outstanding (eoy) m915.5092.15 993.5%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.52.2 113.5%   
Avg P/E ratio x24.055.5 43.2%  
P/CF ratio (eoy) x21.321.0 101.6%  
Price / Book Value ratio x3.23.4 94.6%  
Dividend payout %13.922.4 62.0%   
Avg Mkt Cap Rs m213,40322,830 934.7%   
No. of employees `00010.15.5 184.3%   
Total wages/salary Rs m13,5492,209 613.3%   
Avg. sales/employee Rs Th8,536.61,910.1 446.9%   
Avg. wages/employee Rs Th1,347.9405.0 332.8%   
Avg. net profit/employee Rs Th885.575.5 1,173.6%   
INCOME DATA
Net Sales Rs m85,81010,419 823.6%  
Other income Rs m37647 802.1%   
Total revenues Rs m86,18610,466 823.5%   
Gross profit Rs m50,2181,349 3,721.8%  
Depreciation Rs m1,117677 164.9%   
Interest Rs m35,295235 15,012.9%   
Profit before tax Rs m14,182484 2,930.2%   
Minority Interest Rs m2780-   
Prior Period Items Rs m390-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,59972 7,732.8%   
Profit after tax Rs m8,901412 2,162.6%  
Gross profit margin %58.512.9 451.9%  
Effective tax rate %39.515.0 263.9%   
Net profit margin %10.44.0 262.6%  
BALANCE SHEET DATA
Current assets Rs m385,9995,373 7,184.2%   
Current liabilities Rs m260,4894,157 6,266.4%   
Net working cap to sales %146.311.7 1,253.3%  
Current ratio x1.51.3 114.6%  
Inventory Days Days68968 1,016.7%  
Debtors Days Days11273 153.4%  
Net fixed assets Rs m7,5386,244 120.7%   
Share capital Rs m916184 496.7%   
"Free" reserves Rs m65,7916,566 1,002.1%   
Net worth Rs m66,7066,750 988.3%   
Long term debt Rs m273,0611,233 22,149.6%   
Total assets Rs m635,13512,363 5,137.6%  
Interest coverage x1.43.1 45.8%   
Debt to equity ratio x4.10.2 2,241.2%  
Sales to assets ratio x0.10.8 16.0%   
Return on assets %7.05.2 133.0%  
Return on equity %13.36.1 218.8%  
Return on capital %14.79.0 162.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1903,762 5.0%   
Fx outflow Rs m571,143 5.0%   
Net fx Rs m1332,619 5.1%   
CASH FLOW
From Operations Rs m-111,3751,227 -9,075.5%  
From Investments Rs m-23,283-1,360 1,711.9%  
From Financial Activity Rs m148,346-388 -38,263.2%  
Net Cashflow Rs m13,508-521 -2,594.8%  

Share Holding

Indian Promoters % 37.3 59.2 63.0%  
Foreign collaborators % 0.1 0.0 -  
Indian inst/Mut Fund % 0.0 12.5 -  
FIIs % 21.1 6.0 351.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.5 22.4 185.3%  
Shareholders   134,647 12,805 1,051.5%  
Pledged promoter(s) holding % 52.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare EDELWEISS FINANCIAL With:   TALWALKARS BETTER VALUE  TIMKEN INDIA  RELIGARE ENT.  BAJAJ FINANCE  JSW HOLDINGS  



Today's Market

Sensex Gains 300 Points; Hero MotoCorp & Maruti Suzuki Top Gainers(12:30 pm)

Share markets in India have extended early morning gains and are presently trading higher. Signs of easing trade tension between the US and China provided some respite to investors globally.

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

EDELWEISS FINANCIAL Announces Quarterly Results (4QFY19); Net Profit Down 0.8% (Quarterly Result Update)

May 16, 2019 | Updated on May 16, 2019

For the quarter ended March 2019, EDELWEISS FINANCIAL has posted a net profit of Rs 2 bn (down 0.8% YoY). Sales on the other hand came in at Rs 29 bn (up 12.6% YoY). Read on for a complete analysis of EDELWEISS FINANCIAL's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

EDELWEISS FINANCIAL Announces Quarterly Results (3QFY19); Net Profit Up 9.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, EDELWEISS FINANCIAL has posted a net profit of Rs 3 bn (up 9.2% YoY). Sales on the other hand came in at Rs 28 bn (up 34.1% YoY). Read on for a complete analysis of EDELWEISS FINANCIAL's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

EDELWEISS FINANCIAL SHARE PRICE


Oct 15, 2019 03:19 PM

TRACK EDELWEISS FINANCIAL

  • Track your investment in EDELWEISS FINANCIAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON EDELWEISS FINANCIAL

EDELWEISS FINANCIAL 5-YR ANALYSIS

COMPARE EDELWEISS FINANCIAL WITH

MARKET STATS